Please log in to view this page
Username
Password
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
